SU719492A3 - Способ получени пептидов или их солей - Google Patents
Способ получени пептидов или их солейInfo
- Publication number
- SU719492A3 SU719492A3 SU762379659A SU2379659A SU719492A3 SU 719492 A3 SU719492 A3 SU 719492A3 SU 762379659 A SU762379659 A SU 762379659A SU 2379659 A SU2379659 A SU 2379659A SU 719492 A3 SU719492 A3 SU 719492A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- salts
- preparing peptides
- pip
- measures
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/064—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for omega-amino or -guanidino functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
- C12Q2337/10—Anilides
- C12Q2337/12—Para-Nitroanilides p-NA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
- C12Q2337/30—Naphthyl amides, e.g. beta-NA, 2-NA, 4-methoxy-beta-naphthylamine, i.e. 4MNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
СПОСОБ 1К): УЧГНИЯ ПГ.ПТИДОВ или их СОЛЕЙ
I V;п1ЧиИИ1 (Т1()С1тс к CMKJCoOy iio.ixTei - и(ч:1 ::.U)ii, iioiibix бпо,К)1ически ;II T;;;; ):x );.л;::1е :ии. ;()торыс MOiyi ii;ni:i: ;;p;; (::(:,;(, i; п;:1),;и и KVUiiliH;t.
И ичг:т;;;()в исип.: :,зук); Mr:.vi iir;ч ;:1: и;;г( I иг р; ии:| аи11 ие;п11;и1ой лс::: |().чи;;и1 И актлвирО|5аииь х амиил ; кг:- , иаир1:мс;1 актшмюоваииых (jiiipoB
I
си11;ир1-::.;- и.1л их солеи. .;. почаюиилли в , ч:о еоелпиеиие обол (рлрмулм
где R значени ,
иолвергакуг |;:5аим()ле1 1етвию е соответст: лои1еГ| амииок11елото11, и далее требуемую ;ег:тид 1ук) структуру постепенно нарашиьа;- (1т путем еочетани остальных аминокис .1ОТ, груии} R используют в качест:ie заии1Т 1оГ1 д;1 C кoнueвoi карбокси .плюи груииы nepHOii аминокислоты.
В eiiHTe.ie пептидно цеии используют oci;oiiin,ie методы пентидноГ химии.
.очет;и ие двух амииок1 с.тот и.ш дипен:Л1а 11 а инок1:елот1 осуществл ют, иредва;ител1лю активиру а-карбоксильную :ру;1пу. Лкт1ЛИ1рованное ироизвод ое может ирелсгавл ть eooofi /i-иитрофениловыи. трнX . юрфеииловыЛ, иентахлорфеииловьп или Х-океисукипнимидны сложный эфир, симх;етп1;ч1 1 ,111 ;ли асимметр11чны11 ангидрид, азид кислоты Х-оксибснзотрпазо.товый м /1ллл: 7dи:p.
сиигеза eocToirr в иостади1П1ом ;очетаи1:и гмшюкис.тот с агмииильнс) груиг лк содср/каикм коицевоГ атом у|мерода, ) -же осиаиимп ой еоир жениоп )мо (ролис груиио), KOTOpasi ведет себ как карбоксизгли1:тпа i-руииа пли сна.бжена ; л 1Л(Л л емо карбокеилаии1тио11 груииой,
I:;: 1Л :-(),28i; a h - 33,0 (c 1.0, л.; ;; :,..
;|):;|)) .
II PS мер 3. (Л)о-Pip-Aro;(X()j) -pXA, |;()т ii уСсЮип х, опнсаииых в примере 2. BLixoas, г (86%).
Ре:;у:1ыаты ana.iiKia. Ilpu;;yivT : омо: смиьь:
2),2 (е 1,0, ;i,HMeTiL.i(})(.;ii;i).
При м е р 4. СЬо-I he-Pip-Лг(-|Х().- рХЛ .
2,8 г (5 .ммоль) СЬо-Pip-.Argl.XO;)рХЛ декарбобензоксилируют в броАшетоBi jOiOaiioii кис;1()те, осаждают, iipOMiJiiaidi Д 1ути;и)иым эфиром и сушат, как c):i,icaiio ;; i: ;)i: Мере 2.
:г.;ем HBi-HPip- -Лг((Х(),| рХЛ ;;ае .. :::.1о-: 1 15 М.1 Д1:М1,т,|;|()ор ;;;м;:да, Р::еi::i )p . IX, :;:/1:дг:1)т ДО тем пер ат у р Ь; X X, XliaH.iHiOT 0,9 л;/ .-;aM; ;;a. .чл.дих : (, П) , ) г, к ()етатк .iiio : 3.:i г (7,;о мм(;,|;,) (.,(, Р:г ОрХ: ,. :. .IM , ка-ечти,- ivai a.iзаюра ,1;Д;.:; .;:,; ; ё . о. I:. i X-(1 :; ;бе1М(;трпа ,:;.. 4k-; , 1 I I 11 p;ai :;;:o i i io 1 ;и:дч; ио.-:о,
luT па IOii, при компатно ;ia i ре. 3:;Г1: еарега :) доехха :р; liniin/Kv ;::.;.;, ::u :i.::::. Оетато;.; рает:;TI;I:OT , зт: е:;; :; v, .)рабат;; нан:т 2-; ым рае; е;;о : б;:к;;:.. )ii,;:a натри;; и водой, хпаппва от. ()./;,; :ч1.-. ;К : );.;i(ri i; л:е:а:().1е и хромат;, р;;.;:; р И;-; -.:. е.чЬаде;-;ее- Ы1-:0. iia6 -xiii;. м :; ;ч-;е: : ( : V.; io;p i()T ме а n;i.;o. I :i ;:i:; ;; ;. iiei дапмы.: Г( .X и.чиетен пч-мч lii- . Пв-.од 2,7 ; (73% ).
Ре Л, ii,та; В aiia,iii; a. Т(Х i Р (..;.
175 Ml- (0,246 iмo.ii,l Cho П Piie ir (;i --Art 1 XO:;) - - iX. обраба ;ч,1ва :OT 5 M.i бe.;i;oдiioг() фтор1;е11И;; ;() в iipi;v reTiiiiii 0,3 NB i aii;i3(),ia ; а,.;арат ре Paixai iiбара ii TeMLiiiie 60 M;i;i ;i;ei iVP. игвоiiHKiT iieei фт() iTJii в(.Дор(ет, ев:рои iijX)i i)4i;i;ia i(Vi i д;;е етадви.
.. Ге.;в-хрОл;ато: pacji;;;i lia , еефаде е (j-15, i a6 e uiei4;i в 33%-ном растворе хкеуеной i;e.-iOTbi в воде. 11ое, неiio;i:;ByK )T таюке в качеетве paeTBopine.iSi и B.;i ;ei;ia. M;ieTbiii нродук; ехшат BBiMOjia/Kis1-;а .пие.м емеен .ji Kite.юта - вода.
Ь. lloHHBiii на ко;;опке Ссфадскс У.А1,-25-х.1ор ;д|;о фо;пи-, iia6yxiiicio в смеei; AjeTaiio, - iKTia (95 ; 5i e 11р1;менен 1ем i.e Же ере,;в: ;i ; ечеетве paeT;iOpiiTe.: i: .Bliii.a. MiieBei вродхч-;: ехзва; :пл;.;ора ; :ii5aв;:l ; ;:;; ;.Д.в В;.ход 120 мг (
|е;-;у. iieieiTB; .ia. 11;1од и 1 ;ч)л;о;-( ,|П Vo 4(:Х ;; А ;ч.;ич;;ма R,, -22 ie 0.5; 50;,.-па у; еуе11а м;е .в:;,;, ;и:,д1е;;:. Х .де 1;- ча:;;;е х..ор;..;а iX j37;
11 Р ;. л; е р е, 1; Pie Pro .rirр д.
-il.. iio.; еа ;о ; i; ч . 4.;i./;, (;; i;eai i;B; ; ;;; ;.;i р;, е. .:д / i .
Ре;) .i;era ;в-; а;;а,;в.а. 11род 1 т i4) ;1 ;i;; TAX ;; А |;чл;вч;;;;а ,221;
; : .).() ie .;,.); оО и. i i;e-; о;ч ;-;;-;ve; l l.fiep
При e;i 10. П )- Phe- -Pi;) -.;-с рХ.Д211(:. 11|1.. ;;o,()T п ye.oBi: ;X,
I;;;еаiMiiJx ;; i;Bi;N:e ie 8. A()i 77
,2i
;;в;е го ТСХ ii Р: nKMii4;iiia ; . О, i ; I ,: р 38, Р (е 1.0, Д11Мет; ;;(к). ; .
Пример (i. ( J(j- I he--Pro .ЛгцдХО iXA no.iyqaio в еоотвс тетвии e.:.-iiivvi; , (Miiuaiiiii.iM; : ilpil iepe 4. H;,ivfi; :,;) r
П р ii мер IX П Pip-. -:АА2П ( 1. Проду1 ; iiiMyijaior в e.ioви x, o;i;i;-:;;;; ;х ;i iipii-eeiu 8. 5в1ход 55-,.
Ле;в; е;;:;д; ; а. Продукт i();0i44iТГХ i- . (; е;;;;ч;1иа Rf 0,n i;
i, (e 1,0 .1сЬор ам1;д 1.
И p I; M e p 7. Pbo -I)--Pile - P;-o .i, XO:1 - pX. ifj.iy-iaiOT ii eoo ; ве;е I;:;.; ei его:г)бом, ofiiieaniiiTM в ;) мерс- -I Be: .; I ( ).
e л . ана.изе. Г1род и т е()м;е e;;iiBin
;;o TX ; P (ii(Mi 4inia R;(l.-fi); 1.2 I e 1,0; .;iMeTi, ;ф{)рма)11д).
iibii ;;о тех в Р | ве. пч;;ва 1% 0,50). IlniiNien i.i. П n-v-T T -Pin- ЛгоР - ;io.;y4aKVi ;; еоот|Кге ео е;-оеобо ,
:iHer;in:i i i в ;р;;мере 8. Вв1ход ()8%.
Ре;пм;,та iT,i а;;а.ч::;;. i4)ie i4Miib;i; j;o Ti:;X ; Р; (Be,-ii;ii ;Ha R.rr(1..J4); hb- 75,2 le 0.5; 505:,м1а -Ke -eiiaB xiic .BTia iuviii;:H). «(1дер кав1:е х.юрида 10,
,т:-ч-ек;1е егд;еп ;-;ав-1о ; l,l% i. П pi; мер 14. Abo -A/c--Ar r(XOA--pXA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7507975-6A SE407405B (sv) | 1975-07-11 | 1975-07-11 | Nya kromogena trombinsubstrat |
Publications (1)
Publication Number | Publication Date |
---|---|
SU719492A3 true SU719492A3 (ru) | 1980-02-29 |
Family
ID=20325116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU762379659A SU719492A3 (ru) | 1975-07-11 | 1976-07-09 | Способ получени пептидов или их солей |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS5224590A (ru) |
AT (1) | AT348686B (ru) |
AU (1) | AU497547B2 (ru) |
BE (1) | BE843970A (ru) |
CA (1) | CA1068261A (ru) |
CH (1) | CH622287A5 (ru) |
CS (1) | CS196314B2 (ru) |
DD (1) | DD128691A5 (ru) |
DE (1) | DE2629195C3 (ru) |
DK (1) | DK145799C (ru) |
ES (1) | ES449739A1 (ru) |
FI (1) | FI56525C (ru) |
FR (1) | FR2317280A1 (ru) |
GB (1) | GB1510926A (ru) |
IL (1) | IL49829A (ru) |
IT (1) | IT1062605B (ru) |
NL (1) | NL188355C (ru) |
NO (1) | NO142576C (ru) |
PL (1) | PL103003B1 (ru) |
SE (1) | SE407405B (ru) |
SU (1) | SU719492A3 (ru) |
ZA (1) | ZA763586B (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5255593A (en) * | 1975-10-30 | 1977-05-07 | Ajinomoto Kk | Measuring method of enzyme activity |
DE2757992A1 (de) * | 1977-12-24 | 1979-06-28 | Boehringer Mannheim Gmbh | Verfahren zur prothrombin-bestimmung |
DE2812943C3 (de) * | 1978-03-23 | 1981-05-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma |
US4289498A (en) * | 1979-01-08 | 1981-09-15 | Ortho Diagnostics, Inc. | One-stage prothrombin assay and compositions useful therein |
DE3061860D1 (en) * | 1979-04-24 | 1983-03-17 | Marcel Jozefonvicz | Process for the determination of proteases and antiproteases |
FR2471410A2 (fr) * | 1979-12-17 | 1981-06-19 | Jozefonvicz Marcel | Perfectionnements apportes a un procede de dosage des proteases et des anti-proteases et notamment des proteases et antiproteases des systemes de la coagulation et du complement |
DE3005540A1 (de) * | 1980-02-14 | 1981-08-20 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und reagens zur bestimmung der biologischen aktivitaet von heparin im plasma |
DK155051C (da) * | 1980-05-06 | 1989-07-03 | Pentapharm Ag | Tripeptidderivater samt fremgangsmaade til kvantitativ analyse for proteolytiske enzymer under anvendelse deraf |
JPS5856695A (ja) * | 1981-09-28 | 1983-04-04 | Nitto Boseki Co Ltd | 新規なトロンビン測定用基質 |
DE3211254A1 (de) * | 1982-03-26 | 1983-09-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zum nachweis des vorliegens einer allergie und zum spezifischen nachweis des fuer die allergie verantwortlichen allergens |
DK201084A (da) * | 1983-04-28 | 1984-10-29 | Kimberly Clark Co | Fremgangsmaade til bestemmelse af cathepsin b i naervaerelse af andre proteolytiske enzymer, og forbindelser til anvendelse ved fremgangsmaaden |
US20090075298A1 (en) | 2005-05-20 | 2009-03-19 | Mitsubishi Kagaku Iatron, Inc. | Method of analyzing enzyme |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE380258B (sv) * | 1972-05-02 | 1975-11-03 | Bofors Ab | Nya diagnostiskt verksamma substrat med hog specificitet till trypsin och andra enzymer av typen peptidyl-peptid-hydrolaser |
SE380257B (sv) * | 1972-05-02 | 1975-11-03 | Bofors Ab | Nya diagnostiskt verksamma substrat med hog specificitet till trombin och andra proteolytiska enzymer av typen peptidyl-peptid-hydrolaser |
-
1975
- 1975-07-11 SE SE7507975-6A patent/SE407405B/xx not_active IP Right Cessation
-
1976
- 1976-06-16 ZA ZA763586A patent/ZA763586B/xx unknown
- 1976-06-17 IL IL49829A patent/IL49829A/xx unknown
- 1976-06-21 GB GB25580/76A patent/GB1510926A/en not_active Expired
- 1976-06-25 AU AU15305/76A patent/AU497547B2/en not_active Expired
- 1976-06-25 AT AT463976A patent/AT348686B/de not_active IP Right Cessation
- 1976-06-29 DE DE2629195A patent/DE2629195C3/de not_active Expired
- 1976-06-29 NL NLAANVRAGE7607104,A patent/NL188355C/xx not_active IP Right Cessation
- 1976-07-06 CA CA256,417A patent/CA1068261A/en not_active Expired
- 1976-07-08 CS CS764544A patent/CS196314B2/cs unknown
- 1976-07-09 FI FI762010A patent/FI56525C/fi not_active IP Right Cessation
- 1976-07-09 SU SU762379659A patent/SU719492A3/ru active
- 1976-07-09 FR FR7621196A patent/FR2317280A1/fr active Granted
- 1976-07-09 ES ES449739A patent/ES449739A1/es not_active Expired
- 1976-07-09 NO NO762407A patent/NO142576C/no unknown
- 1976-07-09 CH CH887476A patent/CH622287A5/de not_active IP Right Cessation
- 1976-07-09 PL PL1976191068A patent/PL103003B1/pl unknown
- 1976-07-09 BE BE168774A patent/BE843970A/xx not_active IP Right Cessation
- 1976-07-09 DD DD7600193785A patent/DD128691A5/xx unknown
- 1976-07-09 DK DK312676A patent/DK145799C/da not_active IP Right Cessation
- 1976-07-09 IT IT50364/76A patent/IT1062605B/it active
- 1976-07-10 JP JP51082442A patent/JPS5224590A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU719492A3 (ru) | Способ получени пептидов или их солей | |
Ringer | Concerning the influence exerted by each of the constituents of the blood on the contraction of the ventricle | |
Galanis et al. | Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas | |
EP1171624B1 (en) | Method and means for producing high titer, safe, recombinant lentivirus vectors | |
DE60033045T2 (de) | Lentivirale triplex-dns, und vektoren und rekombinante zellen, die lentivirale triplex-dns enthalten | |
Van Kaam | Lung-protective ventilation in neonatology | |
DE19909769A1 (de) | Von SIVagm abgeleitete lentivirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in Säugerzellen | |
Kobinger et al. | Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells | |
EP3801842A2 (en) | Process for preparing lithium chemical compounds by electrodialysis method and apparatus for performing this process | |
DE2522335B2 (de) | Strahldüse zum Transportieren eines Schußfadens durch ein Webfach mittels eines strömenden Transportmittels | |
CH617157A5 (ru) | ||
Mselli-Lakhal et al. | Gene transfer system derived from the caprine arthritis–encephalitis lentivirus | |
DE762903C (de) | Herstellung von Polyphosphaten | |
Chang et al. | Maslinic acid activates mitochondria-dependent apoptotic pathway in cardiac carcinoma | |
DE2456667A1 (de) | Verfahren zum stabilisieren von calciumhydrogenphosphat-anhydrid gegen die umsetzung mit fluorionen | |
US20200339341A1 (en) | Chlorine Dioxide Generating Aerosol | |
DE1923993C3 (de) | Verfahren zur Steuerung von Kn Stalltracht und wachstum bei der hy drothermalen Herstellung von alpha Calcium sulfat Halbhydrat | |
Dugheri et al. | Novi pristup procjeni profesionalne izloženosti antineoplasticima u bolničkom okruženju | |
DE1012610B (de) | Verfahren zur Herstellung von Dioxy-dialkoxybenzophenonen | |
DE1466968A1 (de) | Produkt zur Herstellung von Zahnabdruecken und Verfahren zur Herstellung dieser Abdruecke | |
WO2001092506A1 (en) | Siv derived lentiviral vector systems | |
Nueistae et al. | Myosalvarsan. Dioxydiaminoarsenobenzol. dimethansulfonsaures N a-trium. Sulpharsenbenzen, Sulpharsenol, Sulpharsphenamin. Myroxylon balsamum (L.) Harms var. genuinum. Myroxylon balsa· mum L. var. physiologiea toluifera Tsehireh, Myroxylon toluifera HBK | |
US317821A (en) | Baking-powder | |
Cates et al. | Venom Unleashed Vol. 1 | |
DE806453C (de) | Verfahren zur Herstellung von trockenen, nicht hygroskopischen Doppelsalzen aus Calciumsalzen aliphatischer Carbonsaeuren und Chlorcalcium |